By THE ASSOCIATED PRESS
Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer.
Published: October 3, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1iSbrHr
from WordPress http://ift.tt/1Rll2Tb
via Hadi Aboukhater
No comments:
Post a Comment